about
Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public HealthHormesis effects of silver nanoparticles at non-cytotoxic doses to human hepatoma cellsExtreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-low doses of Gelsemium sempervirens.A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.Quantitative assessment of inhalation exposure and deposited dose of aerosol from nanotechnology-based consumer sprays.Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodispositionMultiweek resting EEG cordance change patterns from repeated olfactory activation with two constitutionally salient homeopathic remedies in healthy young adults.The Trend Towards Implementing the Precautionary Principle in us Regulation of NanomaterialsTesting the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effectsActivity Variation of Phanerochaete chrysosporium under Nanosilver Exposure by Controlling of Different Sulfide Sources.The effects of nanomaterials as endocrine disruptorsHomeopathic medications as clinical alternatives for symptomatic care of acute otitis media and upper respiratory infections in children.Integrative nanomedicine: treating cancer with nanoscale natural products.Oxidative stress by inorganic nanoparticles.Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.A method to evaluate hormesis in nanoparticle dose-responses.Hormetic Response by Silver Nanoparticles on In Vitro Multiplication of Sugarcane (Saccharum spp. Cv. Mex 69-290) Using a Temporary Immersion System.Hormesis and Homeopathy: Toward a New Self-Consciousness.Neurobehavioral toxicity of carbon nanotubes in mice.Effects of prenatal exposure to single-wall carbon nanotubes on reproductive performance and neurodevelopment in mice.Differential Genomic Effects of Six Different TiO2 Nanomaterials on Human Liver HepG2 Cells.Nanoparticle Exposure and Hormetic Dose-Responses: An Update.Human Biomonitoring of Engineered Nanoparticles: An Appraisal of Critical Issues and Potential Biomarkers
P2860
Q28384520-01BE9EA8-A1E1-4FCC-BA8F-A226FD8944AFQ33916318-7FDD6694-D10D-4AC9-940D-FE5F2A5F21D3Q34410758-CA14C49C-E849-4FCA-9188-7598722253EEQ34454233-61A397AA-6831-4A91-994E-B0F410E89BD6Q34459663-1F874390-E48E-41D5-8C8A-A91F4D9AFA87Q35665569-7DE09795-AA6F-4DEA-833D-BB30DEB6556EQ35965114-0733AD07-8A0A-4BA3-B015-8A393FFF88E8Q36197720-21617EA1-5590-40AF-A004-A357F53EFC42Q36515121-7EA84421-8087-4C03-BFB4-5FA0D828D803Q36569507-45F445CD-4C8F-407B-BE07-388499E74CE2Q37139223-1994F805-2FE2-4022-9E0A-FBFEFE46C783Q37324073-455BCD91-8BAC-4E49-AEE7-BAB92AEAE10EQ37578847-AFFC1BD8-3037-438F-8659-17E21E6A33FEQ38584750-9868D054-0773-4EA8-95C0-ADD809DB819AQ40000942-20D0B337-DED2-42E5-A4E9-670A96CAD788Q42321831-BFC47608-66F7-40A9-90AE-B1A60DA9322AQ46241834-33D8C15A-0397-4565-BE2A-75AD71AF42F6Q47095057-2E2B0DBE-5735-4BD0-AA2C-83A79278B991Q47426671-C02FC7B3-982B-4F29-AA61-3A30B28DA7ACQ47773238-967FE36F-A75B-4D1A-A5E9-1FFC1E6B28E9Q51491394-A246A5AF-4F7A-42DE-8DC6-CCBE3CE5AAA2Q52657760-3C3E14FA-72AF-45A4-A35B-D96699213861Q58910342-1BA544A7-8F3B-4A2D-9CF8-3685E7823506
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Exposure to nanoparticles and hormesis.
@ast
Exposure to nanoparticles and hormesis.
@en
Exposure to nanoparticles and hormesis.
@nl
type
label
Exposure to nanoparticles and hormesis.
@ast
Exposure to nanoparticles and hormesis.
@en
Exposure to nanoparticles and hormesis.
@nl
prefLabel
Exposure to nanoparticles and hormesis.
@ast
Exposure to nanoparticles and hormesis.
@en
Exposure to nanoparticles and hormesis.
@nl
P2093
P2860
P1433
P1476
Exposure to nanoparticles and hormesis.
@en
P2093
Edward J Calabrese
Ivo Iavicoli
Marc A Nascarella
P2860
P304
P356
10.2203/DOSE-RESPONSE.10-016.IAVICOLI
P577
2010-08-12T00:00:00Z